Home » Authors » James Etheridge

Articles by James Etheridge

Innate Pharma Grants License To Clinical Data For Diagnostic

Nov. 15, 2006

By James Etheridge

IDM Pharma Seeking European OK For Mepact In Osteosarcoma

Nov. 15, 2006

By James Etheridge

Cerenis Series B Round Brings In €42M For Clinic

Nov. 15, 2006

By James Etheridge

IDM Pharma Seeking European OK For Mepact In Osteosarcoma

Nov. 15, 2006

By James Etheridge

Innate Pharma Grants License To Clinical Data For Diagnostic

Nov. 15, 2006

By James Etheridge

Cerenis Series B Round Brings In €42M For Clinic

Nov. 15, 2006

By James Etheridge

No Abstract

IntegraGen, Royal DSM Partner In Area Of Weight Management

Nov. 8, 2006

By James Etheridge

Innate Pharma Completes €30M Initial Public Offering In Paris

Nov. 8, 2006

By James Etheridge

Innate Pharma Completes €30M Initial Public Offering In Paris

Nov. 8, 2006

By James Etheridge

No Abstract

IntegraGen, Royal DSM Partner In Area Of Weight Management

Nov. 8, 2006

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026